Stromal endothelial cells are potential targets for new cancer drugs

Sally Church on Pharma Strategy Blog discusses a recent paper from Science and Translational Medicine, in which new research shows that endothelial cells (fibroblasts, immune cells) actively participate in regulating the cancer tumor microenvironment.

Further insight on why stromal-cancer cross talk is becoming a hot-topic, can be found on Pharma Strategy Blog.

, , , , , , , , ,

error: Content is protected !!